Stay updated on Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial

Sign up to get notified when there's something new on the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.16.11 to v2.16.12, and the date has changed from July 14, 2025, to August 11, 2025.
    Difference
    1.0%
    Check dated 2025-08-16T20:17:28.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.10 to v2.16.11.
    Difference
    0.3%
    Check dated 2025-08-09T15:30:30.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    4%
    Check dated 2025-08-02T14:11:08.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and includes the addition of HHS Vulnerability Disclosure.
    Difference
    0.8%
    Check dated 2025-07-26T12:16:34.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.16.5 to v2.16.6 and has changed the date from June 13, 2025, to July 14, 2025.
    Difference
    0.9%
    Check dated 2025-07-19T10:58:19.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    A service alert has been added regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.
    Difference
    4%
    Check dated 2025-07-12T05:07:14.000Z thumbnail image

Stay in the know with updates to Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page.